GLYQA ('sweet' in Greek) is a mobile phone-based product, offering symptom management and smart interventions for complications arising from Diabetes and associated comorbidities. Diabetes is one of the diseases with profound complications, including heart disease, stroke, kidney failure, loss of limbs, and retinopathy. Diabetes affects 25.8 million people which is 8.3% of the U.S. population, costing us about $245 Billion. We are the first product to combine predictive modeling, machine learning and care practices to introduce interventions for Diabetes and associated complications.
We drew inspiration from a study conducted by the University of Stirling, UK, which concluded that a mobile phone-based Advanced Symptom Management System (AsyMS) can support the management of symptoms in patients receiving chemotherapy for lung, breast, and colorectal cancer. More information on this study can be found at pubmed.gov under the link http://www.ncbi.nlm.nih.gov/pubmed/18953579
Glyqa is now available on
Apple Appstore and Google Play!
Glyqa is a cloud-based smart-tech therapeutic platform used by providers to deliver coordinated care-plans for patients suffering from diabetes
Ability for the Doctor/Nurse to review patient reported data on GLYQA and deliver one-off recommendations or a comprehensive care plan.
Ability for the patient to report Symptoms at real-time versus waiting for an appointment.
Patients not having to enter their physical activity and other health metrics, if already recorded on Apple Health.
apple healthkit integration
Reminders for medication adherence like a virtual pill box.
diabetes complication risk scores
Patients and Doctors being able to track the progression of the disease state (along with complications arising from Diabetes)